Tracked deals
3
3 tracked deals across 2020-2022.
Operating Company
Healthcare
Altasciences
Laval, Quebec, Canada
Integrated drug development solution company offering a one-stop approach to early-phase drug development, including preclinical research, clinical pharmacology, drug formulation, manufacturing and analytical services, bioanalysis, program management, and related services.
- Focus Areas
- Preclinical research & toxicology, Clinical pharmacology (early-phase/Phase I), Contract Research Organization (CRO)
- Website
- altasciences.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
3 buyout
Altasciences Acquisition Volume by Year
Last 3 years
Supporting Data
Recent Transactions
-
January 4, 2022
- Buyer
- Altasciences
- Target
- Sinclair Research
- Industry
- Healthcare Services
- Location
- Missouri, United States
- Type
- Buyout
Altasciences completed the acquisition of Sinclair Research, a Midwest-based preclinical CRO, expanding its U.S. preclinical footprint and adding capacity and toxicology expertise. The deal brings Sinclair’s over-80-animal-room capabilities into Altasciences’ integrated CRO/CDMO platform to better support biopharmaceutical, animal health, and medical device development programs.
-
February 12, 2021
- Buyer
- Altasciences
- Target
- WCCT Global, Inc.
- Industry
- Healthcare Services
- Location
- California, United States
- Type
- Buyout
Altasciences acquired WCCT Global, an early‑stage clinical research organization (CRO) based in Southern California, expanding its West Coast clinical pharmacology capabilities and adding 180 clinical beds. The transaction, completed February 12, 2021, augments Altasciences’ Phase I/II services and expertise in specialized areas such as ethnobridging to support biopharmaceutical sponsors.
-
February 27, 2020
- Buyer
- Altasciences
- Target
- Alliance Contract Pharma
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Type
- Buyout
Altasciences, a mid-size contract research organization based in Laval, Quebec, has acquired Alliance Contract Pharma to add small-molecule contract manufacturing and analytical services, including commercial manufacturing, GMP warehouse storage, and clinical supply distribution. The acquisition expands Altasciences' integrated early‑phase drug development offering by adding manufacturing and analytical capabilities to its preclinical, clinical, and bioanalytical services.
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
2 tracked deals by Altasciences.
Pharmaceuticals Buyers & Acquisitions
1 tracked deal by Altasciences.
Acquisitions in California
1 tracked deal by Altasciences.
Acquisitions in Missouri
1 tracked deal by Altasciences.
Acquisitions in Pennsylvania
1 tracked deal by Altasciences.
Selling a company? Get in front of buyers like Altasciences
Turn tracked acquisition activity into an outreach-ready buyer list.